Atlas Trials

Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving Adalimumab

Clinical trial NCT01428115 · COMPLETED

Trial details

NCT number
NCT01428115
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Study type
OBSERVATIONAL
Severe Crohn's DiseaseAnxiety
Start date
2011-12-01
Primary completion
2013-10-01
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.